Lung cancer in patients with HIV infection and review of the literature Authors
Received: 28 August 2003 Accepted: 21 January 2004 DOI:
Cite this article as: Spano, J., Massiani, M., Bentata, M. et al. Med Oncol (2004) 21: 109. doi:10.1385/MO:21:2:109 Abstract Background. The improved survival of patients since the use of highly active antiretroviral treatments has lead to the reporting of non-AIDS defining tumors, such as lung cancer. Methods. Analysis of the records of 22 HIV-infected patients with lung cancer (LC) diagnosed in three hospitals located in the Paris area (France). Results. Twenty-one patients were smokers. The patients (86% male, 14% female) had a median age of 45 yr (range, 33–64 yr). Risk factors for HIV infection were intravenous drug use in 5 patients, homosexual transmission in 10 patients, and heterosexual transmission in 7 patients. At diagnosis of LC, seven patients had previously developed a CDC-defined AIDS manifestation, the median CD4 cell count was 364/mm 3 (range 20–854/mm 3) and median HIV1 RNA viral load was 3000 copies/mL. The most frequent histological subtype was squamous cell carcinoma (11 cases). A stage III–IV disease was observed in 75% of the patients. Only one patient had a small-cell lung carcinoma. Twenty-one patients received combined specific therapy, of which six patients underwent surgery for the LC. The median overall survival was 7 mo. No opportunistic infections occurred during LC therapy. Conclusions. LC occurs at a young age in HIV-infected smokers. LC is not associated with severe immunodeficiency. The prognosis is poor because of their initial extensive disease and a poor response to therapy. However, surgery appears to improve outcome in much the same way as in the general population. Key Words Lung cancer HIV infection clinical characteristics outcome therapy survival Download to read the full article text References
Goedert JJ. The epidemiology of acquired immunodeficiency syndrome malignancies.
Sem Oncol 2000; 27:390–401.
Wallace JM. HIV and the lung.
Curr Opin Pulm Med
Irwin LE, Begandy MK, Moore TM. Adenosquamous carcinoma of the lung and the acquired immunodeficiency syndrome.
Ann Intern Med
Fraire AE, Awe RJ. Lung cancer in association with human immunodeficiency virus infection.
Flores MR, et al. Lung cancer in patients with human immunodeficiency virus infection.
Am J Clin Oncol
Vyzula R, Remick SC. Lung cancer in patients with HIV infection.
Alshafie MT, Donaldson B, Oluwole SF. Human immunodeficiency virus and lung cancer.
Br J Surg
Tirelli U, et al. Lung carcinoma in 36 patients with human immunodeficiency virus infection.
Mountain CF. A new international staging system for lung cancer.
CDC. 1993 Revised Classification System for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults.
MMWR 1993; 41 (No RR-17):1–19.
Surveillance du sida en France.
BEH 2001; 24:111–117.
Parker MS, Leveno DM, Campbell TJ, Worrell JA, Carozza SE. AIDS-related bronchogenic carcinoma, fact or fiction?
Burns DN, et al. Cigarette smoking: a modifier of human immunodeficiency virus type 1 infection.
J Acquire Immun Def Syndr 1991; 4:76–83.
Karp J, Profeta G, Marantz PR, Karpel JP. Lung cancer in patients with immunodeficiency syndrome.
Sridhar KS, Flores MR, Raub WA Jr, Saldana M. Lung cancer in patients with human immunodeficiency virus infection compared with historic control subjects.
Gruden JF, Webb WR, Yao Dc, Klein JS, Sandhu JS. Bronchogenic carcinoma in 13 patients infected with the human immunodeficiency virus (HIV): clinical and radiographic findings.
J Thorac Imaging
Phelps R. Incidence of lung and invasive cervical cancer in HIV-infected women. 13th International AIDS Conference, Durban, South Africa, 2000, abstr. B 3168.
Hader SL, Smith DK, Moore JS, Holmberg SD. HIV infection in women in the United States: status at the millennium.
Bazot M, et al. Computed tomographic diagnosis of bronchogenic carcinoma in HIV-infected patients.
Jasmer RM, et al. Clinical and radiographic predictors of the etiology of pulmonary nodules in HIV-infected patients.
PORT Meta-analysis Trialists Group. Postoperative radiotherapy in non-small cell lung cancer: systemic review and meta-analysis of individual patient data from nine randomized controlled trials.
Costleigh BJ, Miyamoto CT, Micaily B, Brady LW. Heightened sensitivity of the oesophagus to radiation in a patient with AIDS.
Am J Gastroenterol
Spiro SG, Porter JC. Lung cancer—where are we today? Current advances in staging and nonsurgical treatment.
Am J Respir Crit Care Med
Kivisto KT, Kroemer HK, Eichelbaum M. The role of human cytochrome p450 in the metabolism of anticancer agents.
Br J Clin Pharmacol
Grulich AE, Wan X, Law MG, Coates M, Kaldor JM. Risk of cancer in people with AIDS.
Bower M, et al. HIV-related lung cancer in the era of highly active antiretroviral therapy.
Rabkin CS, Aranda CP, Rom WN. Cancer incidence in a population with a high prevalence of infection with human immunodeficiency virus type 1.
J Natl Cancer Inst
Gapuchin-Garcia A, Selwyn PA, Budner NS. Populationbased study of malignancies and HIV infection among injecting drug users in New York City methadone treatment program, 1985–1991.
Herida M, et al. Incidence of non-AIDS defining cancers before and during the highly active antiretroviral therapy era in a cohort of human immunodeficiency virus-infected patients.
J Clin Oncol